Zoetis Inc
NYSE:ZTS
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
Biotechnology
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Realty Income Corp
NYSE:O
|
Real Estate
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
| US |
|
Walt Disney Co
NYSE:DIS
|
Media
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
This note will be permanently deleted.
Zoetis Inc
Zoetis Inc
Other Long-Term Assets
Zoetis Inc
Other Long-Term Assets Peer Comparison
JNJ
BMY
PFE
MRK
LLY
Competitive Other Long-Term Assets Analysis
Latest Figures & CAGR of Competitors
| Company | Other Long-Term Assets | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Zoetis Inc
NYSE:ZTS
|
Other Long-Term Assets
$459m
|
CAGR 3-Years
30%
|
CAGR 5-Years
25%
|
CAGR 10-Years
14%
|
|
|
Johnson & Johnson
NYSE:JNJ
|
Other Long-Term Assets
$19.9B
|
CAGR 3-Years
14%
|
CAGR 5-Years
13%
|
CAGR 10-Years
7%
|
|
|
Bristol-Myers Squibb Co
NYSE:BMY
|
Other Long-Term Assets
$5.5B
|
CAGR 3-Years
26%
|
CAGR 5-Years
11%
|
CAGR 10-Years
10%
|
|
|
Pfizer Inc
NYSE:PFE
|
Other Long-Term Assets
$16.1B
|
CAGR 3-Years
30%
|
CAGR 5-Years
26%
|
CAGR 10-Years
12%
|
|
|
Merck & Co Inc
NYSE:MRK
|
Other Long-Term Assets
$11.1B
|
CAGR 3-Years
4%
|
CAGR 5-Years
6%
|
CAGR 10-Years
2%
|
|
|
Eli Lilly and Co
NYSE:LLY
|
Other Long-Term Assets
$10.3B
|
CAGR 3-Years
17%
|
CAGR 5-Years
18%
|
CAGR 10-Years
16%
|
See Also
What is Zoetis Inc's Other Long-Term Assets?
Other Long-Term Assets
459m
USD
Based on the financial report for Mar 31, 2024, Zoetis Inc's Other Long-Term Assets amounts to 459m USD.
What is Zoetis Inc's Other Long-Term Assets growth rate?
Other Long-Term Assets CAGR 10Y
14%
Over the last year, the Other Long-Term Assets growth was 51%. The average annual Other Long-Term Assets growth rates for Zoetis Inc have been 30% over the past three years , 25% over the past five years , and 14% over the past ten years .
You don't have any saved screeners yet
